Identifying Adult Patients with Non-Relapsing Secondary Progressive Multiple Sclerosis Using Algorithms in US-Based Healthcare Databases
Author(s)
Greene N1, Gibbs SN2, Broder M2, Farnett L1, Chang E2, Campos C2, Higuchi K1
1Sanofi, Cambridge, MA, USA, 2Partnership for Health Analytic Research (PHAR), LLC, Beverly Hills, CA, USA
Presentation Documents
OBJECTIVES: This study aimed to develop and validate algorithms to identify adult patients with non-relapsing secondary progressive multiple sclerosis (nrSPMS) in electronic health records (EHRs) or healthcare claims databases in the US.
METHODS: Eight algorithms were developed based on cognitive interviews with neurologists. Medical record data (including International Classification of Diseases-10, Current Procedural Terminology, and Healthcare Common Procedure Coding System codes) from 195 MS patients were collected. Algorithm performance (sensitivity, specificity, positive predictive value [PPV] and negative predictive value [NPV]) were tested in the full medical record data and code-only data subset. Face validity was further tested in the IQVIA Pharmetrics Plus® claims database (2016-2020) among MS patients from 2016-2018 who had ≥1 inpatient claim or ≥2 outpatient claims for primary diagnosis of MS ≥30 days apart and were continuously enrolled for 2 years since one of their MS diagnoses.
RESULTS: Out of the 8 clinically recommended algorithms and hundreds of variations, the 2 best-performing algorithms used evidence of multi-system involvement (i.e., mobility dysfunction, brain/brain stem dysfunction, other) or ≤1 DMT use, and lack of relapse during study period to identify the nrSPMS state. In full medical record/code-only data, both algorithms resulted in 93%/92% sensitivity, 74%/84% specificity, 86%/90% PPV, and 87%/86% NPV. In the IQVIA database, 33,244 patients with MS were identified. The algorithms identified 19,661 and 19,783 patients with nrSPMS, respectively. Demographic, clinical, and utilization characteristics of these patients were reported.
CONCLUSIONS: The proposed algorithms showed high performance when tested in medical record data. Additionally, the algorithms identified a cohort of patients in claims data that appeared consistent with clinically identified patients with nrSPMS. These algorithms can be applied in other US EHR or claims-based datasets to facilitate further research and better describe the nrSPMS population.
Conference/Value in Health Info
Value in Health, Volume 26, Issue 6, S2 (June 2023)
Code
MSR52
Topic
Economic Evaluation
Topic Subcategory
Value of Information
Disease
No Additional Disease & Conditions/Specialized Treatment Areas